A clinical trial of BLU-667 for non-small cell lung cancer, medullary thyroid cancer and other RET-altered tumors.
Patient safety is the most important part of everything we do at the Siteman Cancer Center, and that principle is applied to each of our clinical trials.
St. Louis Clinical Trial Location
Washington University School of Medicine, Siteman Cancer Center
4921 Parkview Pl
St. Louis, MO 63110